| |
- Pioneering development of disease modifying therapeutics for Alzheimer’s disease and related neurodegenerative disorders
- Discovery of small molecule and antibody therapeutics by targeting the neurotoxic tau oligomers that impair learning and memory and that cause spread of disease in the brain
Back to Company Overview
|